Senti Biosciences Inc. has entered into a securities purchase agreement to raise approximately $47.6 million by issuing 21,157 shares of Series A Convertible Preferred Stock and warrants to purchase up to 31,735,500 shares of common stock, with the initial closing expected on December 5, 2024.